查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1732823

單細胞分析市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、技術、細胞類型、應用、最終用戶、地區和競爭細分，2020-2030 年

Single-Cell Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technique, By Cell Type, By Application, By End User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球單細胞分析市場價值為 39.8 億美元，預計到 2030 年將達到 72.1 億美元，複合年成長率為 10.41%。該市場代表了生物醫學創新的前沿，能夠對基因組學、腫瘤學、免疫學和神經病學等各個學科的單一細胞進行高解析度的詢問。個人化醫療需求的不斷成長是一個主要的成長動力，因為研究人員和臨床醫生採用單細胞技術為個別患者量身定做治療方案，提高治療效果並降低成本。在細胞層面上表徵腫瘤異質性的能力極大地促進了癌症研究和診斷。此外，單細胞 RNA 定序和高通量成像等創新正在擴展分析能力，推動其在藥物開發和疾病研究中的應用。隨著投資激增和應用範圍擴大，單細胞分析正在發展成為生命科學領域的變革工具，加速發現並促進全球精準醫療的進步。

市場概覽
預測期 2026-2030
2024年市場規模 39.8億美元
2030年市場規模 72.1億美元
2025-2030 年複合年成長率 10.41%
成長最快的領域 儀器
最大的市場 北美洲

關鍵市場促進因素

癌症盛行率上升推動市場

主要市場挑戰

數據複雜度與解釋

主要市場趨勢

多組學整合

目錄

第1章：服務概述

  • 市場定義
  • 市場範圍
    • 覆蓋市場
    • 考慮學習的年限
    • 主要市場區隔

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球單細胞分析市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品（消耗品、儀器）
    • 依技術（流式細胞儀、次世代定序、PCR、顯微鏡、質譜、其他技術）
    • 依細胞類型（人類、微生物、動物）
    • 按應用（研究領域、醫學領域）
    • 按最終用戶（學術和研究實驗室、生物技術和製藥公司、醫院和診斷實驗室、細胞庫和 IVF 中心）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美單細胞分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲單細胞分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太單細胞分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 南
    • 澳洲

第9章：南美洲單細胞分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲單細胞分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 14 章：競爭格局

  • Thermo Fisher Scientific Inc.
  • Qiagen NV
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Merck KGaA
  • 10X Genomics.
  • Takara Bio Inc.
  • Standard BioTools Inc.
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 15212

The Global Single-Cell Analysis Market was valued at USD 3.98 billion in 2024 and is projected to reach USD 7.21 billion by 2030, growing at a CAGR of 10.41%. This market represents the forefront of biomedical innovation, enabling high-resolution interrogation of individual cells across various disciplines including genomics, oncology, immunology, and neurology. Increasing demand for personalized medicine is a major growth driver, as researchers and clinicians employ single-cell technologies to customize treatments for individual patients, enhancing therapeutic efficacy and reducing costs. The ability to characterize tumor heterogeneity at the cellular level has significantly advanced cancer research and diagnostics. Furthermore, innovations such as single-cell RNA sequencing and high-throughput imaging are expanding analytical capabilities, driving adoption in drug development and disease research. As investments surge and applications broaden, single-cell analysis is evolving into a transformative tool across life sciences, accelerating discoveries and fostering precision healthcare advancements globally.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.98 Billion
Market Size 2030USD 7.21 Billion
CAGR 2025-203010.41%
Fastest Growing SegmentInstruments
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Cancer is Driving the Market

Cancer's global burden continues to rise, with over 19.3 million new cases and 10 million deaths reported in 2020, a figure expected to grow to more than 35 million new cases by 2050. This escalating prevalence is fueling the growth of the single-cell analysis market. Unlike traditional methods, single-cell analysis reveals tumor heterogeneity, allowing for the detection of rare and therapy-resistant cell populations. This capability enhances our understanding of cancer progression and resistance mechanisms. Furthermore, it plays a pivotal role in precision oncology by identifying cell-specific mutations and expression profiles to guide personalized treatment strategies. Through integrative approaches such as single-cell sequencing of genomics, transcriptomics, proteomics, and metabolomics, researchers can deeply probe cancer biology, fostering the development of targeted and effective therapies. As single-cell techniques gain traction in clinical oncology, their application continues to drive the expansion of the market.

Key Market Challenges

Data Complexity and Interpretation

The granularity of single-cell analysis yields massive and complex datasets that are challenging to manage and interpret. Unlike bulk analysis, which provides averaged results across cell populations, single-cell techniques generate data on a per-cell basis, leading to high-dimensional datasets that require advanced storage, processing, and analytical infrastructure. Additionally, the diversity of data types-ranging from scRNA-seq to single-cell proteomics and epigenomics-complicates integration efforts. Extracting actionable insights from this multi-layered information demands sophisticated bioinformatics tools and expert data interpretation, posing a barrier for widespread adoption, particularly in non-specialized research and clinical settings.

Key Market Trends

Multi-Omics Integration

The integration of multiple omics layers-genomics, transcriptomics, proteomics, and metabolomics-at the single-cell level is emerging as a transformative trend in the market. This comprehensive analytical approach enables researchers to construct a holistic understanding of cellular function and disease pathology. By capturing diverse molecular profiles within individual cells, multi-omics integration facilitates the identification of novel biomarkers, mechanisms of disease progression, and therapeutic targets. This capability is accelerating breakthroughs in precision medicine and is being widely adopted in both academic research and pharmaceutical development. As demand grows for deeper biological insights, this trend is expected to significantly enhance the scope and impact of single-cell technologies.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Danaher Corporation
  • Becton, Dickinson and Company.
  • Merck KGaA
  • 10X Genomics
  • Takara Bio Inc.
  • Standard BioTools Inc.
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.

Report Scope:

In this report, the Global Single Cell Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Single Cell Analysis Market, By Product:

  • Consumables
  • Instruments

Single Cell Analysis Market, By Technique:

  • Flow cytometry
  • Next Generation Sequencing
  • PCR, Microscopy
  • Mass Spectrometry
  • Other techniques

Single Cell Analysis Market, By Cell Type:

  • Human
  • Microbial
  • Animal

Single Cell Analysis Market, By Application:

  • Research Field
  • Medical Field

Single Cell Analysis Market, By End User:

  • Academic & Research laboratories
  • Biotechnology & Pharmaceutical companies
  • Hospital & diagnostic laboratories
  • Cell banks & IVF Centres

Single Cell Analysis Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Single Cell Analysis Market.

Available Customizations:

Global Single Cell Analysis market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Single Cell Analysis Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Instruments)
    • 5.2.2. By Technique (Flow cytometry, Next Generation Sequencing, PCR, Microscopy, Mass Spectrometry, Other techniques)
    • 5.2.3. By Cell Type (Human, Microbial, Animal)
    • 5.2.4. By Application (Research Field, Medical Field)
    • 5.2.5. By End User (Academic & Research laboratories, Biotechnology & Pharmaceutical companies, Hospital & diagnostic laboratories, Cell banks & IVF Centers)
    • 5.2.6. By Region
    • 5.2.7. By Company (2024)
  • 5.3. Market Map

6. North America Single Cell Analysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technique
    • 6.2.3. By Cell Type
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Single Cell Analysis Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Cell Type
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Single Cell Analysis Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Cell Type
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Single Cell Analysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Cell Type
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Single Cell Analysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technique
    • 7.2.3. By Cell Type
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Single Cell Analysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Cell Type
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. United Kingdom Single Cell Analysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Cell Type
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Italy Single Cell Analysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Cell Type
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. France Single Cell Analysis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Cell Type
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Single Cell Analysis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Cell Type
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Single Cell Analysis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technique
    • 8.2.3. By Cell Type
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Single Cell Analysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Cell Type
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Single Cell Analysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Cell Type
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Single Cell Analysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Cell Type
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Single Cell Analysis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Cell Type
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Single Cell Analysis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Cell Type
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Single Cell Analysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technique
    • 9.2.3. By Cell Type
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Single Cell Analysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Cell Type
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Single Cell Analysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Cell Type
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Single Cell Analysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Cell Type
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Single Cell Analysis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technique
    • 10.2.3. By Cell Type
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Single Cell Analysis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Cell Type
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Single Cell Analysis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Cell Type
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Single Cell Analysis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Cell Type
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Competitive Landscape

  • 14.1. Thermo Fisher Scientific Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Qiagen N.V.
  • 14.3. Danaher Corporation
  • 14.4. Becton, Dickinson and Company
  • 14.5. Merck KGaA
  • 14.6. 10X Genomics.
  • 14.7. Takara Bio Inc.
  • 14.8. Standard BioTools Inc.
  • 14.9. Bio-Rad Laboratories Inc.
  • 14.10. Illumina Inc.

15. Strategic Recommendations

16. About Us & Disclaimer